Sciencast Management’s Amedisys AMED Stock Holding History

Sciencast Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,050	Closed	-$367K	–	400
2020 Q1	$367K	Buy	+2,050	New	+$365K	0.1%	147

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sciencast Management's AMED Position: Q2 2020 in Review

Sciencast Management sold out of Amedisys (AMED) in Q2 2020, closing a stake of 2,050 shares — an estimated $367K sold.

Sciencast Management first reported a position in AMED in Q1 2020 and held it in 1 quarter. The position peaked at $367K in Q1 2020. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

Sciencast Management reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
Sciencast Management sold 2,050 Amedisys shares in Q2 2020, an estimated $367K.
Sciencast Management first reported a position in Amedisys in Q1 2020 and held it in 1 quarter.
Sciencast Management's Amedisys position peaked at $367K in Q1 2020.
354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Sciencast Management's 13F filing for Q2 2020, filed 29 Jul 2020.